Salusins: advance in cardiovascular disease research.
Ming-Xin ChenBo-Yan DengShu-Ting LiuZong-Bao WangShu-Zhi WangPublished in: The Journal of pharmacy and pharmacology (2023)
Salusins are discovered in 2003 and divided into salusin-α and salusin-β, which are bioactive peptides with hemodynamic and mitotic activity and mainly distributed in plasma, urine, endocrine glands and kidneys. A large number of studies have shown that salusins can regulate lipid metabolism, inflammatory response and vascular proliferation. Despite the profound and diverse physiological properties of salusins, the exact mechanism of their cardiovascular effects remains to be determined. The potential mechanisms of action of salusins in cardiovascular-related diseases such as atherosclerosis, hypertension, heart failure, myocardial infarction and myocarditis, and their use as biomarkers of cardiovascular disease are discussed. This review aims to provide a new strategy for the diagnosis and prevention of clinical cardiovascular diseases.
Keyphrases
- cardiovascular disease
- heart failure
- inflammatory response
- blood pressure
- left ventricular
- cardiovascular events
- cardiovascular risk factors
- type diabetes
- signaling pathway
- lipopolysaccharide induced
- cell cycle
- intellectual disability
- atrial fibrillation
- fatty acid
- case control
- toll like receptor
- neural network
- human health
- arterial hypertension